Trial Profile
Phase II Clinical Trial of Neoadjuvant Weekly Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel poliglumex (Primary) ; Capecitabine; Cyclophosphamide; Doxorubicin; Methotrexate
- Indications Breast cancer
- Focus Therapeutic Use
- 01 Nov 2010 New trial record